undamentalytics Newsletter

Pacelli Steven Robert: insider trades

Officer at Dexcom. No open-market purchases and 14 sales not made under a pre-set plan, reported from December 12, 2012 to September 13, 2021.

What happened after Pacelli Steven Robert’s sales?

After their sales, the shares moved +42.1% against the index over 12 months on average (a negative figure means selling was the right call); 29% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Pacelli Steven Robert: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 14 +12.3% +7.0% 43% 7 1.28 0.25 No reliable evidence
Sales, 12 months after the report 14 +42.1% +23.6% 29% 7 1.76 0.13 No reliable evidence
Sales, 12 months after the trade 14 +40.7% +22.1% 36% 7 1.64 0.15 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Dexcom DXCM Managing Dir., Dexcom Ventures014December 12, 2012September 13, 2021

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
September 13, 2021September 9, 2021 DXCM Sale $683,747 −4.0%−23.3%−24.6%
March 12, 2021March 10, 2021 DXCM Sale $2,020,013 +5.4%+5.9%+4.5%
September 11, 2020September 9, 2020 DXCM Sale $1,824,214 −20.3%+4.6%+3.5%
March 13, 2020March 11, 2020 DXCM Sale $2,131,565 +68.3%+7.2%−0.8%
September 11, 2019September 9, 2019 DXCM Sale $875,614 +39.5%+147.5%+153.8%
March 13, 2019March 12, 2019 DXCM Sale $1,543,703 −3.8%+68.6%+75.5%
September 12, 2018September 10, 2018 DXCM Sale $788,236 −6.8%−2.7%−5.2%
November 12, 2015November 10, 2015 DXCM Sale $2,117,920 −22.6%−27.8%−33.0%
September 1, 2015August 28, 2015 DXCM Sale $1,879,578 −10.8%−11.0%−14.6%
November 21, 2013November 19, 2013 DXCM Sale $738,530 +37.5%+41.1%+40.1%
November 18, 2013November 14, 2013 DXCM Sale $394,800 +30.8%+40.1%+46.1%
June 12, 2013June 11, 2013 DXCM Sale $111,550 +21.0%+42.3%+39.7%
February 28, 2013February 26, 2013 DXCM Sale $1,123,450 +29.0%+172.3%+177.0%
December 12, 2012December 11, 2012 DXCM Sale $142,600 +8.5%+125.3%+108.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Pacelli Steven Robert traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.